Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
06/2010
06/03/2010US20100136098 Avian influenza vaccine
06/03/2010US20100136093 Immunotherapeutic Method For Increasing Groundnut Tolerance In A Subject
06/03/2010US20100136092 Transdermal immune preparation, method for production of the same, and transdermal immunization method using the same
06/03/2010US20100136061 Light-mediated anti-cell proliferative compositions and methods
06/03/2010US20100136060 Methods of reducing porcine circovirus-associated disease outbreaks
06/03/2010US20100136059 Hybrid operon for expression of colonization factor (cf) antigens of enterotoxigenic escherichia coli
06/03/2010US20100136058 DNA vaccines against tumor growth and methods of use thereof
06/03/2010US20100136057 Virulence of streptococci
06/03/2010US20100136056 Novel insertion sites in pox vectors
06/03/2010US20100136055 Chimeric pestiviruses
06/03/2010US20100136054 Flavivirus ns1 subunit vaccine
06/03/2010US20100136053 Intradermal influenza vaccine
06/03/2010US20100136052 Replication deficient influenza virus for the expression of heterologous sequences
06/03/2010US20100136051 N Protein Muants of Porcine Reproductive and Respiratory Syndrome Virus
06/03/2010US20100136050 Extracellular Matrix Materials as Vaccine Adjuvants for Diseases Associated with Infectious Pathogens or Toxins
06/03/2010US20100136049 Methods and compositions for vaccination of poultry
06/03/2010US20100136048 Live bacterial vaccines resistant to carbon dioxide (co2), acidic ph and/or osmolarity for viral infection prophylaxis or treatment
06/03/2010US20100136047 Recombinant north american type 1 porcine reproductive and respiratory syndrome virus and methods of use
06/03/2010US20100136046 Recombinant polyprotein vaccines for the treatment and diagnosis of leishmaniasis
06/03/2010US20100136045 Novel shigella protein antigens and methods
06/03/2010US20100136043 Composition comprising immunogenic microparticles
06/03/2010US20100136042 Globo h and related anti-cancer vaccines with novel glycolipid adjuvants
06/03/2010US20100136041 Combination gas vaccines and therapeutics
06/03/2010US20100136040 Use of the 7f4 protein in the in vitro diagnosis of mycoplasma pneumoniae infections
06/03/2010US20100136039 Borrelia antigens
06/03/2010US20100136038 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines
06/03/2010US20100136037 polypeptides include somatostatin-14 fused to a substantially inactivated chloramphenicol acetyl transferase protein via a functionally optimized linker; chimeric polypeptides provide highly effective and low cost materials for use in the animal husbandry field; increasing milk production
06/03/2010US20100136036 Unconventional antigen translated by a novel internal ribosome entry site elicits antitumor humoral immune reactions
06/03/2010US20100136035 Method for modulating atherosclerosis
06/03/2010US20100136034 Novel multimeric molecules, a process for preparing the same and the use thereof for manufacturing medicinal drugs
06/03/2010US20100136033 METHODS OF TREATMENT USING ANTI-ErbB ANTIBODY-MAYTANSINOID CONJUGATES
06/03/2010US20100136032 Trimeric ox40-immunoglobulin fusion protein and methods of use
06/03/2010US20100136031 Anti-cxcr1 compositions and methods
06/03/2010US20100136030 Antagonist ox40 antibodies and their use in the treatment of inflammatory and autoimmune diseases
06/03/2010US20100136029 Use of Tri-Substituted Glycerol Compounds for the Treatment of Hematological Malignancies
06/03/2010US20100136028 Antagonists of pcsk9
06/03/2010US20100136027 Methods and Compositions for Treating Bacterial Infection
06/03/2010US20100136026 Ship Inhibition to Direct Hematopoietic Stem Cells and Induce Extramedullary Hematopoiesis
06/03/2010US20100136025 Viral inactivation during purification of antibodies cross reference to related applications
06/03/2010US20100136024 Selective Inhibition of Histone Deacetylase 6 for Ocular Neuroprotection or for Treatment or Control of Glaucoma
06/03/2010US20100136023 Therapeutic agents
06/03/2010US20100136022 Method for modulating the immune response by activating or inactivating the notch and/or stat4 signal path
06/03/2010US20100136021 Tgf-beta binding antibodies
06/03/2010US20100136020 Uses of il-174 antagonists for inhibiting a th2 immune response
06/03/2010US20100136019 Modulating regulatory t cell activity via interleukin 35
06/03/2010US20100136018 Anti-FC-receptor single domain antibodies (nanobodies-tm) and therapeutic use
06/03/2010US20100136017 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer
06/03/2010US20100136016 Heat shock proteins from mycobacterium leprae and uses thereof
06/03/2010US20100136015 Methods and compositions for regulating iron homeostasis by modulation of bmp-6
06/03/2010US20100136014 GIPs, a Family of Polypeptides with Transcription Factor Activity that Interact with Goodpasture Antigen Binding Protein
06/03/2010US20100136013 Cd55-interaction partners and the uses thereof
06/03/2010US20100136012 Variants of vegfr and their use in the diagnosis and treatment of pregnancy associated medical conditions
06/03/2010US20100136011 Antibodies that bind to obm
06/03/2010US20100136010 Novel 27875, 22025, 27420, 17906, 16319, 55092 and 10218 molecules and uses therefor
06/03/2010US20100136009 OVR110 Antibody Compositions and Methods of Use
06/03/2010US20100136008 TACI-Fc Fusion Proteins, Methods of Making and Uses Thereof
06/03/2010US20100136007 Csf1r extracellular domain fusion molecules and treatments using same
06/03/2010US20100136006 Treatment of osteolytic disorders and cancer using csf1r extracellular domain fusion molecules
06/03/2010US20100136005 Method of Treatment Using Humanized Anti-CD11a Antibodies
06/03/2010US20100136004 Compositions and methods for treating neurological disorders
06/03/2010US20100136003 Uses of mammalian cytokine; related reagents
06/03/2010US20100136002 Methods for treating and preventing multiple sclerosis
06/03/2010US20100136001 Methods and compositions for the treatment and diagnosis of vascular inflammatory disorders or endothelial cell disorders
06/03/2010US20100136000 Treatment of follicular lymphomas using inhibitors of the lt pathway
06/03/2010US20100135999 Quinoline-carboxamide derivatives as p2y12 antagonists
06/03/2010US20100135998 Combination therapy for treatment of immune disorders
06/03/2010US20100135997 Polypeptide monomers and dimers containing mutated ilt
06/03/2010US20100135996 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii)
06/03/2010US20100135995 Methods of modulating angiogenesis
06/03/2010US20100135994 Hiv vaccine based on targeting maximized gag and nef to dendritic cells
06/03/2010US20100135993 Method of treating malignant mesothelioma
06/03/2010US20100135992 Prolongation of Survival of an Allograft by Inhibiting Complement Activity
06/03/2010US20100135991 Antibodies recognizing oxygen-regulated protein 150 expressed on cancer cells and methods of using same
06/03/2010US20100135990 Modulation of NR2F6 and methods and uses thereof
06/03/2010US20100135989 Anti-hiv agents
06/03/2010US20100135988 Methods for identifying agents for preventing or treating proliferative diseases, and for inhibiting extracellular matrix or alpha1 type IV collagen
06/03/2010US20100135987 Isolation and purification of antibodies using protein a affinity chromatography
06/03/2010US20100135986 Compositions for anti-fibrinolytic treatment
06/03/2010US20100135985 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them an uses thereof
06/03/2010US20100135975 CD133 Epitopes
06/03/2010US20100135960 Antiviral acylsulfonamide derivatives
06/03/2010US20100135958 Method for treating cancer in humans
06/03/2010US20100135957 Chimeric Heteromultimer Adhesins
06/03/2010US20100135956 Steroid modulators of progesterone receptor and/or glucocorticoid receptor
06/03/2010US20100135955 HUMAN M2e PEPTIDE IMMUNOGENS
06/03/2010US20100135953 Method of treatment of age-related macular degeneration
06/03/2010US20100135951 Agents and Methods Related to Reducing Resistance To Apoptosis-Inducing Death Receptor Agonists
06/03/2010US20100135948 Anti-Autoimmune Antibodies for Treatment of Pemphigus
06/03/2010US20100135904 Compositions and methods for the inhibition of cripto / grp78 complex formation and signaling
06/03/2010US20100135900 Cd37 immunotherapeutic combination therapies and uses thereof
06/03/2010CA2750147A1 Anticancer composition comprising antitumor agent and substance having inhibitory effects on l1cam activity and expression
06/03/2010CA2745620A1 Transformed soybean plant which accumulates vaccine, and use thereof
06/03/2010CA2745012A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cylophosphamide
06/03/2010CA2745005A1 Antitumor combinations containing antibodies recognizing specifically cd38 and cytarabine
06/03/2010CA2744996A1 Antitumor combinations containing antibodies recognizing specifically cd38 and vincristine
06/03/2010CA2744990A1 Antitumor combinations containing antibodies recognizing specifically cd38 and melphalan
06/03/2010CA2744823A1 Treating neoplasms with neurotoxin
06/03/2010CA2744587A1 Compositions with reduced dimer formation
06/03/2010CA2744454A1 Recombinant avian influenza vaccine and uses thereof
06/03/2010CA2744354A1 Method for production of ph stable enveloped viruses
1 ... 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 ... 1823